Ignite Creation Date:
2024-05-06 @ 6:50 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05808608
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-09-25
First Post:
2023-03-23
Brief Title:
A Study of AK104 Plus Axitinib in AdvancedMetastatic Special Pathological Subtypes of Renal Cell Carcinoma
Sponsor:
Hao Zeng
Organization:
West China Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-09
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-23
First Submit QC Date:
April 10 2023
Study First Post Date:
2023-04-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-21
Last Update Post Date:
2023-09-25
Last Update Post Date Type:
ACTUAL